301 results on '"Zaaijer, Hans L."'
Search Results
2. Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation
3. Assessing West Nile virus (WNV) and Usutu virus (USUV) exposure in bird ringers in the Netherlands: a high-risk group for WNV and USUV infection?
4. A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients
5. Hepatitis B core related antigen in relation to intrahepatic and circulating viral markers, before and after combination therapy
6. JC and Human polyomavirus 9 after kidney transplantation: An exploratory serological cohort study
7. The Elecsys® Anti-SARS-CoV-2 and Elecsys® Anti-SARS-CoV-2 S antibody assays: Differentiating between vaccination and infection, and assessing long-term performance.
8. Potential human transmission of amyloid β pathology: surveillance and risks
9. Low SARS-CoV-2 seroprevalence in blood donors in the early COVID-19 epidemic in the Netherlands
10. Peg-interferon plus nucleotide analogue treatment versus no treatment in patients with chronic hepatitis B with a low viral load: a randomised controlled, open-label trial
11. Stability of BK polyomavirus IgG seroreactivity and its correlation with preceding viremia
12. Hepatitis B Virus Pregenomic RNA Is Present in Virions in Plasma and Is Associated With a Response to Pegylated Interferon Alfa-2a and Nucleos(t)ide Analogues
13. Dynamics of the Immune Response in Acute Hepatitis B Infection
14. Viral metagenomics in drug-naïve, first-onset schizophrenia patients with prominent negative symptoms
15. Risk factors for hepatitis E virus seropositivity in Dutch blood donors
16. Viral minority variants in the core promoter and precore region identified by deep sequencing are associated with response to peginterferon and adefovir in HBeAg negative chronic hepatitis B patients
17. Cost‐effectiveness of the screening of blood donations for hepatitis E virus in the Netherlands
18. Hepatitis B Surface Antigen Decline and Clearance During Long-Term Tenofovir Therapy in Patients Coinfected With HBV and HIV
19. Human polyomavirus 9 infection in kidney transplant patients
20. Incidence and duration of hepatitis E virus infection in Dutch blood donors
21. Rare transmission of hepatitis B virus by Dutch donors with occult infection
22. Two decades of risk factors and transfusion-transmissible infections in Dutch blood donors
23. An inventory of concerns behind blood safety policies in five Western countries
24. Long-term Therapy With Tenofovir Is Effective for Patients Co-Infected With Human Immunodeficiency Virus and Hepatitis B Virus
25. Low awareness of past SARS-CoV-2 infection in healthy plasma donors
26. No Artifact, Hepatitis E Is Emerging
27. Declining prevalence of hepatitis E antibodies among Danish blood donors
28. The yield of universal antibody to hepatitis B core antigen donor screening in the Netherlands, a hepatitis B virus low-endemic country
29. Predonation screening of candidate donors and prevention of window period donations
30. Past and present of hepatitis E in the Netherlands
31. Screening of blood donors for chronic Coxiella burnetii infection after large Q fever outbreaks
32. Travel-related dengue virus infection, the Netherlands, 2006-2007
33. Estimating the transfusion transmission risk of Q fever
34. Balancing non‐discriminatory donor selection and blood safety in the Netherlands: Evaluation of an individual risk assessment of sexual behavior.
35. Assessing the Threat: Public Health
36. Fourth human parechovirus serotype
37. Reduced serologic response to mumps, measles, and rubella vaccination in patients treated with intravenous immunoglobulin for Kawasaki disease
38. Lookback procedures after postdonation notifications during a Q fever outbreak in the Netherlands
39. Bacterial and Viral Respiratory Tract Microbiota and Host Characteristics in Adults With Lower Respiratory Tract Infections: A Case-Control Study.
40. Genome wide association study of Chronic Hepatitis B patients identified a variation in the SLC16A9 gene which is associated with HBsAg loss after treatment with peginterferon and adefovir: 445
41. HBsAg/anti-HBs immune complex levels predict HBeAg seroconversion in patients treated with peg-interferon and adefovir: 427
42. Coxiella burnetii infection among blood donors during the 2009 Q-fever outbreak in the Netherlands
43. Acute chest syndrome in sickle cell disease due to the new influenza A (H1N1) virus infection
44. Efficacy of hepatitis B virus (HBV) DNA screening and characterization of acute and occult HBV infections among blood donors from Madrid, Spain
45. Convalescent Plasma in a Patient with Protracted COVID-19 and Secondary Hypogammaglobulinemia Due to Chronic Lymphocytic Leukemia: Buying Time to Develop Immunity?
46. Diversity and origin of hepatitis C virus infection among unpaid blood donors in the Netherlands
47. Parvovirus B19 DNA detectable in hearts of patients with dilated cardiomyopathy, but absent or inactive in blood.
48. Quantitative real-time detection of parvovirus B19 DNA in plasma
49. Borrelia burgdorferi sensu lato seroconversion after intravenous immunoglobulin treatment: A cohort study.
50. Blood donor screening in the Netherlands: Universal anti‐HBc screening in combination with HBV nucleic acid amplification testing may allow discontinuation of hepatitis B virus antigen testing.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.